<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Liver involvement is a common finding in patients suffering from <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e>, and histopathological patterns of infiltration vary according to <z:hpo ids='HP_0002665'>lymphoma</z:hpo> subtype </plain></SENT>
<SENT sid="1" pm="."><plain>Data correlating the form of liver involvement with distinct <z:hpo ids='HP_0002665'>lymphoma</z:hpo> subtypes is, however, scarce </plain></SENT>
<SENT sid="2" pm="."><plain>The aim was to review 89 liver biopsies diagnosed with <z:hpo ids='HP_0002665'>lymphoma</z:hpo> infiltration and evaluate the infiltration patterns </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: In equivocal cases, additional immunohistochemical and molecular pathology analyses were performed to differentiate between neoplastic and reactive cell infiltrates and to classify the <z:hpo ids='HP_0002665'>lymphoma</z:hpo> subtypes </plain></SENT>
<SENT sid="4" pm="."><plain>Diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>), <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (CLL), Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>) and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) were the most prevalent subtypes in our series, which included 14 different <z:hpo ids='HP_0002665'>lymphoma</z:hpo> entities in total </plain></SENT>
<SENT sid="5" pm="."><plain>Whereas <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> predominantly demonstrated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> nodules deranging the <z:mpath ids='MPATH_458'>normal</z:mpath> hepatic architecture, CLL and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> mostly showed infiltration of the portal fields </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, distinct <z:hpo ids='HP_0002665'>lymphoma</z:hpo> entities, particularly marginal zone B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e>) and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>, commonly revealed lympho-epithelial lesions of bile ducts, which were observed in 10% of <z:hpo ids='HP_0000001'>all</z:hpo> investigated cases </plain></SENT>
<SENT sid="7" pm="."><plain>Four cases, initially interpreted as T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, proved to be reactive T-cell lesions </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Distinct <z:hpo ids='HP_0002665'>lymphoma</z:hpo> subtypes show characteristic patterns of liver infiltration </plain></SENT>
<SENT sid="9" pm="."><plain>Additional molecular analyses can support diagnosis by verification of clonality or detection of characteristic genetic aberrations </plain></SENT>
</text></document>